| 2001 |
Targeted deletion of the first Ig domain of Dutt1/Robo1 in mice causes delayed lung maturation and bronchial epithelial hyperplasia, establishing Robo1 as required for normal lung development. |
Germline knockout mouse (targeted deletion of exon 2/first Ig domain), histopathology |
Proceedings of the National Academy of Sciences of the United States of America |
High |
11734623
|
| 2002 |
Promoter hypermethylation of ROBO1/DUTT1 silences its expression in breast and renal cell carcinoma, and 5-aza-2'-deoxycytidine treatment reactivates expression, supporting epigenetic inactivation as a two-hit tumor suppressor mechanism. |
Bisulfite sequencing, methylation-specific analysis, 5-aza-2'-deoxycytidine demethylation, RT-PCR, LOH analysis |
Oncogene |
High |
12082532
|
| 2004 |
Robo1 heterozygous mice spontaneously develop lymphomas and lung adenocarcinomas, with promoter methylation silencing the remaining wild-type allele in tumors, confirming Robo1 as a classic two-hit tumor suppressor. |
Heterozygous knockout mouse, LOH analysis, methylation analysis, Western blot, immunohistochemistry |
Cancer research |
High |
15374951
|
| 2006 |
Robo1 knockout mice display axon pathfinding defects (corpus callosum and hippocampal commissure dysgenesis, premature corticothalamic/thalamocortical targeting) and increased cortical interneuron migration, demonstrating Robo1's role in forebrain axon guidance and interneuron migration in vivo. |
Targeted knockout mouse, MRI diffusion tensor imaging, immunohistochemistry, axon tracing |
Development (Cambridge, England) |
High |
16690755
|
| 2010 |
ROBO1 ectodomain is shed by metalloproteinases, followed by gamma-secretase cleavage producing two C-terminal fragments (CTF1 at 129 kDa, CTF2 at 118 kDa), and the resulting intracellular fragment accumulates in the nucleus in cancer cells; this nuclear translocation is blocked by metalloproteinase or gamma-secretase inhibitors. |
Pharmacological inhibition (TAPI-1, L-685,458), Western blot, cellular fractionation, mass spectrometry of cleavage sites |
FEBS letters |
High |
20471383
|
| 2010 |
Decreased miR-218 levels eliminate repression of Robo1, activating the Slit2-Robo1 pathway (via Slit2-Robo1 interaction) to promote gastric cancer metastasis; restoration of miR-218 suppresses Robo1 expression and inhibits tumor cell invasion in vitro and in vivo. |
miRNA overexpression/restoration, in vitro invasion assay, in vivo xenograft, luciferase 3'UTR reporter assay |
PLoS genetics |
High |
20300657
|
| 2010 |
miR-218 directly targets the 3'UTR of ROBO1 mRNA to suppress its expression; enforced expression of miR-218-resistant ROBO1 rescues NPC cell migration, establishing a negative feedback loop wherein miR-218 regulates cell migration via the SLIT-ROBO1 pathway. |
Luciferase 3'UTR reporter assay, rescue with miR-218-resistant ROBO1 isoform, migration assays, in vivo tumor growth |
Cancer research |
High |
21385904
|
| 2010 |
Robo1 mediates Slit2-induced repulsive effects on glioma cell migration; RNAi-mediated knockdown of Robo1 neutralizes Slit2's repulsive effect in a modified Boyden chamber assay, demonstrating Robo1 as the principal Slit2 receptor in glioma cells. |
RNAi knockdown, modified Boyden chamber migration assay, qRT-PCR, immunohistochemistry |
Journal of neuro-oncology |
Medium |
17968499
|
| 2011 |
SLIT2/ROBO1 signaling restrains mammary branching morphogenesis by limiting basal cell proliferation; TGF-β1 induces Robo1 expression specifically in the basal layer, and SLIT2 limits basal cell proliferation by inhibiting canonical WNT signaling, increasing cytoplasmic/membrane β-catenin at the expense of nuclear β-catenin. |
Conditional knockout (basal layer-specific loss of SLIT/ROBO1 signaling), immunostaining, Western blot, mammary gland whole-mount analysis |
Developmental cell |
High |
21664580
|
| 2012 |
Slit2 secreted by stromal fibroblasts activates Robo1 in breast cancer cells to block β-catenin nuclear translocation, downregulating c-myc and cyclin D1 via the PI3K/Akt pathway, thereby restraining breast cancer tumorigenesis. |
Co-culture, Robo1 overexpression/knockdown, PI3K/Akt pathway inhibitors, β-catenin localization assays, in vivo xenograft |
Cancer research |
High |
22826604
|
| 2012 |
RabGDI, an essential component of vesicle fusion machinery, regulates Robo1 surface expression on commissural axons in vertebrates; downregulation of RabGDI causes axons to stall in the floor plate (phenocopying Robo1 loss), while premature RabGDI expression prevents floor plate entry, and RabGDI directly triggers Robo1 surface expression in cultured commissural neurons. |
In ovo RNAi, immunofluorescence, cultured commissural neuron assay, gain-of-function and loss-of-function genetics (chick) |
Neural development |
High |
23140504
|
| 2012 |
ROBO1 interaction with DOCK1 (at SH3-SH2 domain) controls Rac activation; loss of ROBO1 results in Rac1 activation, causing E-cadherin/β-catenin cytoskeleton destabilization and induction of cell migration in prostate cancer cells. |
ROBO1-expressing/ROBO1-C2C3-mutant constructs, immunoprecipitation, confocal microscopy, luciferase reporter, migration assays |
International journal of cancer |
Medium |
24752651
|
| 2013 |
srGAP1 is a Robo1-interacting protein; Slit2-Robo1 signaling inhibits Cdc42 activity and colorectal cancer cell motility through srGAP1, as shown by co-immunoprecipitation and subcellular co-localization after Slit2 treatment. |
Immunoprecipitation, immunofluorescence, small GTPase pull-down assay, modified wound healing assay |
Journal of experimental & clinical cancer research |
High |
27923383
|
| 2013 |
Heparin binds to Robo1 with ~650 nM affinity; N-sulfo and 6-O-sulfo groups are essential for Robo1-heparin binding; Robo1 prefers full-length heparin chains, and GAGs with higher sulfation show increased Robo1 binding affinity. |
Surface plasmon resonance (SPR), chemically modified heparin competition assay, heparin oligosaccharide size-series binding |
Biochimie |
High |
23994753
|
| 2014 |
FLRT3 is a novel co-receptor for Robo1; in the presence of Slit1, both Robo1 and FLRT3 are required to induce Netrin-1 attraction via upregulation of surface DCC through activation of protein kinase A, revealing a context-dependent modulation of guidance cue responses. |
Co-immunoprecipitation, axon guidance assays in vitro and in vivo (thalamic axon guidance in mouse), surface DCC measurement, PKA activation assay |
Current biology : CB |
High |
24560577
|
| 2014 |
The crystal structure of the extracellular juxtamembrane (JM) domains of human Robo1 reveals structural similarity to neogenin/DCC netrin-binding regions; a conserved surface overlapping oncogenic mutations is identified, and exposure or relief of the folded JM linker enhances ectodomain shedding of Robo1 in cultured cells. |
X-ray crystallography, structural comparison, cell-based ectodomain shedding assay |
Journal of structural biology |
High |
24607414
|
| 2015 |
Two separate heparin binding sites on Robo1 were identified by hydroxyl radical protein footprinting: one at the previously characterized site and a second N-terminal site (disordered in crystal structure); mutagenesis of the N-terminal site decreases heparin binding affinity, and heparin binding induces conformational changes in the Ig2 domain. |
Electron transfer dissociation-based hydroxyl radical protein footprinting, site-directed mutagenesis, SPR, heparin affinity chromatography |
The Journal of biological chemistry |
High |
25752613
|
| 2015 |
Slit2 signaling through Robo1 and Robo2 promotes retinal neovascularization by driving endothelial cell migration; Robo1/2 are required for both Slit2- and VEGF-induced Rac1 activation and lamellipodia formation in endothelial cells. |
Conditional knockout mice (Slit2, Robo1, Robo2), retinal angiogenesis assays, Rac1 activation assay, lamellipodia formation assay, endothelial cell migration assay |
Nature medicine |
High |
25894826
|
| 2015 |
Slit2-Robo1 signaling activates hepatic stellate cells (HSCs) to promote liver fibrosis through phosphorylation of Smad2, Smad3, PI3K, and AKT in an TGF-β1-independent manner; Robo1 neutralizing antibody R5 and Robo1 siRNA downregulate these phosphorylation events and inhibit α-SMA expression. |
Robo1 neutralizing antibody, Robo1 siRNA, Western blot (pSmad2/3, PI3K, AKT), primary mouse and human HSC cultures, Slit2 transgenic mice, Robo1/2 heterozygous knockout mice, CCl4 liver injury model |
Journal of hepatology |
High |
26264936
|
| 2015 |
SLIT2/ROBO1 signaling regulates mammary stem cell self-renewal by controlling the choice between asymmetric and symmetric cell divisions through SNAI1 and mINSC; loss of SLIT2/ROBO1 signaling increases nuclear SNAI1, which upregulates mInsc and increases symmetric cell divisions, producing more stem cells and larger mammary outgrowths. |
Conditional knockout, in vivo mammary transplantation, SNAI1 overexpression/knockdown, mInsc expression analysis, spindle orientation assays |
Cell reports |
High |
26440891
|
| 2015 |
Robo2 acts in trans to inhibit Slit-Robo1 repulsion and promote midline crossing in Drosophila; Robo2 binds Robo1 via extracellular domains, and this binding is required for Robo2's ability to promote crossing non-cell autonomously. |
Gain-of-function and rescue genetics in Drosophila, extracellular domain binding studies, non-cell-autonomous overexpression assays |
eLife |
High |
26186094
|
| 2015 |
Recombinant Slit2 reduces peripheral immune cell infiltration after surgical brain injury via the Robo1-srGAP1 pathway, mediating inhibition of Cdc42 activity; decoy Robo1 and srGAP1 siRNA reverse the protective effects, confirming Robo1 as the functional receptor. |
Recombinant protein administration, decoy receptor approach, siRNA knockdown, Cdc42 activity assay, immunohistochemistry, brain edema measurement (rat model) |
Neurobiology of disease |
High |
26550694
|
| 2015 |
Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of Wnt/β-catenin signaling by downregulating E-cadherin; this was demonstrated in Slit2 transgenic mice, ApcMin/+ spontaneous adenoma models, and a DMH/DSS colorectal carcinoma model. |
Slit2 transgenic mice, ApcMin/+ model, DMH/DSS model, Src signaling analysis, E-cadherin/β-catenin Western blot |
Oncotarget |
High |
25605242
|
| 2015 |
Slit2 promotes angiogenesis via the Robo1-VEGFR2-ERK1/2 pathway; Slit2 overexpression upregulates Robo1 and VEGFR2 and activates phospho-ERK1/2 in both transgenic mice and HUVECs in vitro. |
Slit2 transgenic mice, plasmid transfection in HUVECs, Western blot (ERK1/2, AKT, p38), cell proliferation/migration/tube formation assays |
Investigative ophthalmology & visual science |
Medium |
26244297
|
| 2016 |
The integrated heparan sulfate (HS) ligand requirement of Robo1 was determined: Robo1 prefers octasaccharides with 6-O-sulfate esters critical for binding, while C-2 sulfate esters reduce binding; a second low-affinity HS binding site exists at the N-terminus of Robo1, and high-affinity HS ligands can reverse Slit2-Robo1-mediated inhibition of endothelial cell migration. |
Affinity enrichment of HS oligosaccharides, HILIC-HRMS, permethylation/desulfation MS/MS, chemical synthesis, SPR binding assay, endothelial cell migration assay |
Journal of the American Chemical Society |
High |
27611601
|
| 2016 |
NMR characterization of glycosylated Robo1-Ig1-2 interaction with a synthetic HS tetramer identified K81 as part of the binding site (Kd ~255 µM); the bound HS conformation, binding epitope, and role of each glycan residue were characterized. |
Single amino acid type labeling NMR, STD-NMR, trNOE, paramagnetic perturbation, chemical shift perturbation mapping |
ACS chemical biology |
High |
27653286
|
| 2016 |
Dscam1 forms a complex with Robo1 dependent on the N-terminal fragment of Slit (Slit-N); Dscam1 modifies the output of Robo/Slit complexes so that signaling is no longer repulsive but promotes longitudinal axon growth, as shown in Drosophila. |
Biochemical co-immunoprecipitation, genetic double mutants (Dscam1/robo1), slit cleavage allele (slit-UC), transgenic rescue experiments (Drosophila) |
PLoS biology |
High |
27654876
|
| 2016 |
SLIT2/ROBO1 signaling regulates cell shape and matrix adhesion in response to ECM stiffness; Robo1 ablation in the mammary gland compromises actin stress fiber assembly and inhibits cell contractility, while SLIT2 treatment stimulates Rac and increases focal adhesion kinase (FAK) activity to enhance cell tension; stiff ECM increases Robo1 levels by downregulating miR-203. |
Robo1 ablation in vivo, SLIT2 treatment, Rac activation assay, FAK activity assay, actin cytoskeleton imaging, ECM stiffness manipulation, miR-203 modulation |
The Journal of cell biology |
High |
26975850
|
| 2016 |
Robo1 promotes cell migration via Cdc42 and Rac1 GTPases; Src activates Abl kinase to stabilize Robo1 protein levels, and inhibition of Abl kinase by siRNA or kinase blockers decreases Robo1 protein and suppresses transformed cell migration. |
siRNA knockdown of Abl, kinase inhibitors, Western blot for Robo1, GTPase activity assays, cell migration assays |
Oncotarget |
Medium |
21301049
|
| 2016 |
CdGAP (a Rac1- and Cdc42-specific GTPase-activating protein) is identified as a Robo1-interacting protein in HUVECs; Slit2/Robo1 binding drives endothelial cell migration through Robo1-CdGAP interaction, while Robo4 negatively regulates this signaling intracellularly. |
Targeted proteomics with anti-Robo1 monoclonal antibody, co-immunoprecipitation, Boyden chamber migration assay, Robo1/Robo4 knockdown |
Biochemical and biophysical research communications |
Medium |
26713366
|
| 2018 |
Crystal structure of Robo1 Ig1-4 and Ig5 combined with negative stain EM reconstruction shows that the Robo1 ectodomain forms compact dimers mediated by central Ig domains, which further interact 'back-to-back' to generate tetramers; Slit2-N binding does not change Robo1 oligomerization state, suggesting Slit2-N induces a conformational change rather than oligomerization to trigger signaling. |
X-ray crystallography, negative stain electron microscopy reconstruction, fluorescent imaging of Robo1 oligomerization upon Slit2-N interaction, SAXS |
Structure (London, England : 1993) |
High |
29307485
|
| 2018 |
The SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma via activation of the SRC/ERK/c-MYC/PFKFB2 pathway; in vitro and in vivo experiments show SLIT2/ROBO1 promotes proliferation, inhibits apoptosis, and alters metabolic reprogramming. |
In vitro cell assays, in vivo xenograft, Western blot for SRC/ERK/c-MYC/PFKFB2 pathway components, ROBO1 knockdown/overexpression |
Cell death & disease |
Medium |
29523788
|
| 2018 |
miR-92 binds to the 3' UTR of Robo1 mRNA to suppress its translation (not mRNA degradation) in commissural neurons; disruption of miR-92/Robo1 3'UTR interaction induces premature Slit2 repulsion responsiveness of precrossing commissural axons in vitro and causes axon projection defects in vivo. |
3'UTR reporter assay, miR-92 overexpression/inhibition, in vitro Slit2 repulsion assay, in vivo commissural axon guidance (chick) |
Cell reports |
High |
30184503
|
| 2019 |
NOVA splicing factors regulate temporal expression of mammalian ROBO1 and ROBO2 variants via alternative splicing at a conserved microexon, producing isoforms with distinct guidance activities; ROBO-mediated repulsion is activated early via one isoform to prevent premature crossing and inhibited later to allow crossing, then disinhibited postcrossing. |
Alternative splicing analysis, NOVA splicing factor genetics, commissural axon guidance assays, isoform-specific rescue experiments (mouse) |
eLife |
High |
31392959
|
| 2019 |
Recombinant Slit2 reduces neuronal apoptosis after neonatal hypoxic-ischemic encephalopathy via the Robo1-srGAP1 pathway, mediating inhibition of RhoA; decoy Robo1 and srGAP1 siRNA reverse the neuroprotective effects. |
Recombinant protein administration, decoy receptor, srGAP1 siRNA, RhoA activity assay, TUNEL staining, Western blot (rat neonatal HIE model) |
Neuropharmacology |
Medium |
31356825
|
| 2020 |
SLIT2 inhibits macropinocytosis in macrophages and RAS-transformed cancer cells via ROBO1-mediated cytoskeletal changes; in vivo, SLIT2 attenuates muramyl dipeptide uptake to prevent NOD2-dependent NF-κB activation and CXCL1 secretion, and blocking endogenous SLIT2 enhances CXCL1 secretion. |
In vitro macropinocytosis assay, in vivo muramyl dipeptide uptake, NF-κB reporter assay, ELISA, ROBO1 blocking experiments, cytoskeletal imaging |
Nature communications |
High |
32807784
|
| 2020 |
PRRG4 promotes breast cancer metastasis by recruiting the E3 ubiquitin ligase NEDD4 via its LPSY and PPPY motifs, leading to ubiquitination and degradation of Robo1, thereby activating Src and FAK signaling. |
Co-immunoprecipitation, domain-mutant constructs (LPSY/PPPY motif mutations), ubiquitination assay, Western blot, migration/invasion assays, in vivo metastasis model |
Oncogene |
High |
33037408
|
| 2021 |
YY1 directly binds the promoter region of ROBO1 to promote its transcription; ROBO1 inhibits pancreatic cancer proliferation via the CCNA2/CDK2 axis, causing S-phase arrest. |
Luciferase reporter gene assay, chromatin immunoprecipitation (ChIP), electrophoretic mobility shift assay (EMSA), ROBO1 overexpression, flow cytometry (cell cycle), subcutaneous xenograft in nude mice |
Oncogene |
High |
33714986
|
| 2024 |
PTP4A2 (protein tyrosine phosphatase 4A2) modulates self-renewal, proliferation and tumorigenicity in recurrent glioblastoma through a dephosphorylation axis with ROBO1; genetic perturbation or small-molecule inhibition of PTP4A2 exploits functional dependency on ROBO1 signaling, and ROBO1 CAR T cells targeting this receptor doubled median survival in CDX models of recurrent GBM. |
Genome-wide CRISPR screens, integrative genomic analyses, small-molecule PTP4A2 inhibition, ROBO1-targeted CAR T cell engineering, CDX xenograft models |
Nature medicine |
High |
39095594
|
| 2012 |
Slit2N (active N-terminal Slit2 fragment) acting through Robo1 inhibits HIV-gp120-induced migration and podosome formation in immature dendritic cells by inducing Robo1 to bind and sequester WASp and LSP1 from β-actin, and by inhibiting Src signaling and downstream Rac1, Pyk2, paxillin, and CDC42 activation. |
Co-immunoprecipitation, podosome formation assay, transendothelial migration assay, Western blot for Src/Rac1/Pyk2/paxillin/CDC42, siRNA knockdown |
PloS one |
Medium |
23119100
|
| 2020 |
Slit2/Robo1 signaling promotes the survival of intestinal Lgr5+ stem cells under colitis conditions by activating autophagy; Slit2 transgenic mice show increased LC3II/I ratio and maintained Lgr5+ stem cell proliferation, while Robo1/2 partial knockout reduces Lgr5+ stem cells and decreases autophagy markers. |
DSS-induced colitis model, Slit2 transgenic and Robo1/2 heterozygous knockout mice, LC3II/I ratio Western blot, p62 Western blot, Lgr5+ immunofluorescence, qPCR |
International journal of biological sciences |
Medium |
32398956
|